NIH Launches New Office to Advance Human-Based Research Methods

The National Institutes of Health launched a new office in June 2026 dedicated to developing research methods that rely on human biology rather than animal models. The office, called ORIVA, short for the Office of Research Innovation and Validation of Alternatives, will coordinate efforts across NIH to identify, fund, and validate these approaches.

The move reflects growing interest in what researchers call "human-relevant" science. Critics of animal testing have long argued that results from animal studies often fail to translate to human patients, contributing to high failure rates in drug development. Supporters of the new office say better human-based models could improve the accuracy of medical research.

ORIVA will work with academic institutions, biotech companies, and other federal agencies to develop tools such as organ-on-a-chip systems, organoids grown from human cells, and advanced computer models that simulate human physiology.

The office will also set standards for validating these new methods, a step that is required before they can be accepted by regulatory agencies like the FDA. Without validation, even promising new tools cannot be used in the drug approval process.

Public health advocates welcomed the announcement. Several organizations that have pushed for alternatives to animal testing called the launch a meaningful step, though they noted that full adoption of human-based methods across biomedical research will take years.

NIH officials said ORIVA will not eliminate animal research immediately but will work to expand the toolkit available to scientists and reduce reliance on animal models over time.